Veeva Systems Inc. Reports Strong Financial Performance for Q2 2026
Veeva Systems Inc. has released its financial results for the second quarter of fiscal 2026, showcasing impressive growth across its cloud solutions tailored for the life sciences industry. As a leader in providing integrated software, data management, and consulting services, Veeva continues to enhance its offerings, thereby driving both revenue and customer engagement.
1. Overview of Q2 2026 Performance
For the second quarter ending July 31, 2025, Veeva reported total revenues of $789 million, marking a substantial increase from $676.1 million in the same quarter of the previous year. This increase reflects a 16.7% year-over-year growth, underscoring the strong demand for the company's cloud-based solutions across its four primary segments: Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud.
Revenue Breakdown
The revenue growth can be attributed to a significant rise in subscription services, which amounted to $593.1 million, up from $509.6 million in Q2 2025. This segment's growth is primarily driven by robust demand for both R&D and Commercial Solutions.
- R&D Solutions revenue rose to $192.6 million, while Commercial Solutions contributed significantly to the overall revenue with $205.2 million in the same period.
- Professional services also saw an uptick, indicating increasing demand for Veeva's consulting capabilities.
The company's diversified customer base continues to expand, now serving over 1,500 clients, including a mix of established pharmaceutical companies and emerging biotech firms.
| Sep 2024 | Aug 2025 | |
|---|---|---|
Net Income | 615.2M | 809.9M |
Profit | 615.2M | 809.9M |
Net Income Continuing | 615.2M | 809.9M |
Income Tax Expense | 170.0M | 241.6M |
Pretax Income | 785.3M | 1.05B |
Non-operating Income | 199.9M | 252.1M |
Operating Income | 585.4M | 799.4M |
Revenue | 2.57B | 2.96B |
Costs and Expenses | 1.98B | 2.16B |
Cost of Revenue | 685.8M | 724.4M |
Operating Expenses | 1.30B | 1.44B |
Research & Development | 663.9M | 730.6M |
Selling, General & Administrative | 638.3M | 713.6M |
2. Operating Costs and Expenses
Operating costs and expenses for the quarter were reported at $593.1 million, which includes:
- Cost of Revenue: $195.2 million
- Operating Expenses: $397.9 million, which encompasses research and development costs, sales and marketing expenses, and general and administrative costs.
Interestingly, R&D expenses have increased to $192.6 million, reflecting Veeva's commitment to innovation and product development. Sales and marketing expenses also rose to $205.2 million, showcasing the company's efforts to bolster its market presence.
Impact of Employee Compensation
The rise in operating expenses is largely attributed to increased employee compensation costs, which are expected to continue growing as the company invests in talent to support its expanding operations. General and administrative expenses increased notably, reflecting higher costs associated with litigation settlements and stock-based compensation.
3. Profitability Metrics
Veeva reported a net income of $200.3 million for Q2 2026, an increase from $171 million in the same quarter last year. This improvement in profitability reflects the company's effective management of costs alongside its robust revenue growth. The operating income for the quarter stood at $195.9 million, with a pretax income of $265.3 million, illustrating the strong financial health of the organization.
Other Income and Tax Provision
Other income rose to $69.45 million, thanks to higher interest income from increased investment balances. The provision for income taxes also saw a rise due to changes in tax regulations, aligning with the broader economic environment.
4. Cash Flow Analysis
Despite the strong performance on the income statement, Veeva experienced a net change in cash of -$34.55 million for the quarter. This was influenced by significant investing activities, including payments for investments totaling $785.7 million. However, cash generated from operating activities was robust at $238.4 million, highlighting the company's operational efficiency.
| Sep 2024 | Aug 2025 | |
|---|---|---|
Net Change in Cash | 422.1M | 764.6M |
Effect of Exchange Rate Changes | -3.34M | 882K |
Net Cash from Operating Activities | 996.7M | 1.34B |
Operating Profit | 615.2M | 809.9M |
Adjustment to Operating Profit | 381.4M | 539.3M |
Net Cash from Investing Activities | -546.2M | -755.2M |
Investments | 521.0M | 734.0M |
Productive Assets | 25.17M | 21.20M |
Net Cash from Financing Activities | -25.02M | 169.8M |
Equity Issuance/Repurchase | 59.29M | 253.0M |
Other Financing Activities | -84.32M | -83.16M |
5. Balance Sheet Highlights
Veeva’s balance sheet remains strong with total assets of $7.99 billion, an increase from $6.33 billion in the previous year. The company’s equity rose to $6.63 billion, reflecting retained earnings that have accumulated due to consistent profitability.
- Current Assets: $6.99 billion
- Non-Current Assets: $1.00 billion
- Total Liabilities: $1.36 billion
This healthy balance sheet positions Veeva well for future investments and growth opportunities.
| Sep 2024 | Aug 2025 | |
|---|---|---|
Total Assets | 6.33B | 7.99B |
Total Current Assets | 5.36B | 6.99B |
Cash and Equivalents | 1.16B | 1.93B |
Short-term Investments | 3.71B | 4.47B |
Accounts Receivable | 364.7M | 422.0M |
Prepaid Expenses | 78.61M | 118.4M |
Total Non-current Assets | 962.9M | 1.00B |
Intangible Assets | 493.3M | 476.4M |
Non-current Deferred Tax Assets | 291.0M | 309.6M |
Net PP&E | 56.68M | 61.21M |
Lease Assets | 43.14M | 71.53M |
Other Non-current Assets | 78.78M | 86.00M |
Total Liabilities and Equity | 6.33B | 7.99B |
Total Liabilities | 1.14B | 1.36B |
Total Current Liabilities | 1.07B | 1.25B |
Accounts Payable and Accrued Liabilities | 103.8M | 136.6M |
Current Debt | 10.18M | 10.66M |
Current Deferred Revenue | 956.3M | 1.10B |
Total Non-current Liabilities | 75.70M | 105.8M |
Non-current Deferred Tax Liabilities | 591K | 439K |
Other Non-current Liabilities | 75.11M | 105.3M |
Total Equity and Non-controlling Interests | 5.18B | 6.63B |
Total Equity | 5.18B | 6.63B |
6. Conclusion
Veeva Systems Inc. continues to exhibit strong growth in its financial performance, driven by robust demand for its cloud-based solutions in the life sciences sector. The company’s commitment to research and development, along with strategic investments in its workforce, positions it for sustained success in the coming quarters. As Veeva navigates the complexities of operational costs and regulatory changes, its focus on innovation and market engagement is expected to fuel future growth. Investors and stakeholders will be keenly watching Veeva’s strategic moves as it seeks to capitalize on the evolving landscape of the life sciences industry.
